Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAmphastar Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | $0.65 | $0.75 | $0.71 |
| Q2 2026 | 4 | $0.68 | $0.75 | $0.71 |
| Q3 2026 | 3 | $0.81 | $0.89 | $0.85 |
| Q4 2026 | 1 | $0.79 | $0.86 | $0.83 |
| Q1 2027 | 1 | $0.68 | $0.75 | $0.72 |
| Q2 2027 | 1 | $0.74 | $0.81 | $0.78 |
| Q3 2027 | 1 | $0.84 | $0.92 | $0.88 |
| Q4 2027 | 1 | $0.80 | $0.87 | $0.84 |
Amphastar Pharmaceuticals Inc Earnings Date And Information
Amphastar Pharmaceuticals Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $0.42 earnings per share for the quarter, missing analysts' consensus estimates of $0.7 by $0.28. The company had revenue of 171.17 M for the quarter and had revenue of 719.89 M for the year. Amphastar Pharmaceuticals Inc has generated $2 earnings per share over the last year ($2.03 diluted earnings per share) and currently has a price-to-earnings ratio of 10.48. Amphastar Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Amphastar Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | $0.70 | $0.14 | -0.56 | $173.46 M | $171.17 M |
| 02/26/2026 | Q4 2025 | $0.90 | $0.53 | -0.37 | $188.77 M | $183.11 M |
| 11/06/2025 | Q3 2025 | $0.77 | $0.38 | -0.39 | $186.22 M | $191.84 M |
| 08/07/2025 | Q2 2025 | $0.71 | $0.66 | -0.05 | $173.98 M | $174.41 M |
| 05/08/2025 | Q1 2025 | N/A | $0.53 | N/A | $172.94 M | $170.53 M |
| 03/03/2025 | Q4 2024 | N/A | $0.78 | N/A | $188.76 M | $186.52 M |
| 11/07/2024 | Q3 2024 | N/A | $0.83 | N/A | $194.67 M | $188.82 M |
| 08/09/2024 | Q2 2024 | N/A | $0.78 | N/A | $170.96 M | $182.39 M |
| 05/09/2024 | Q1 2024 | N/A | $0.90 | N/A | $174.65 M | $171.84 M |
| 02/29/2024 | Q4 2023 | N/A | $0.75 | N/A | N/A | $178.11 M |
| 11/08/2023 | Q3 2023 | $0.69 | $1.01 | 0.32 | N/A | $180.56 M |
| 08/08/2023 | Q2 2023 | N/A | $0.54 | N/A | N/A | $145.71 M |
| 05/09/2023 | Q1 2023 | $0.48 | $0.54 | 0.06 | N/A | $140.02 M |
| 03/01/2023 | Q4 2022 | N/A | $0.70 | N/A | N/A | $135.02 M |
| 11/07/2022 | Q3 2022 | N/A | $0.32 | N/A | N/A | $120.13 M |
| 08/08/2022 | Q2 2022 | N/A | $0.35 | N/A | N/A | $123.47 M |
| 05/09/2022 | Q1 2022 | N/A | $0.50 | N/A | N/A | $120.37 M |
| 03/11/2022 | Q4 2021 | N/A | $0.41 | N/A | N/A | $120.89 M |
| 11/08/2021 | Q3 2021 | N/A | $0.62 | N/A | N/A | $112.20 M |
| 08/09/2021 | Q2 2021 | $0.21 | $0.16 | -0.05 | N/A | $101.66 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amphastar Pharmaceuticals Inc Earnings: FAQ's
The conference call for Amphastar Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Amphastar Pharmaceuticals Inc's latest earnings report can be read online.
Amphastar Pharmaceuticals Inc (:AMPH) has a recorded annual revenue of $719.89 M.
Amphastar Pharmaceuticals Inc (:AMPH) has a recorded net income of $98.09 M.Amphastar Pharmaceuticals Inc has generated $2.1 earnings per share over the last four quarters.
Amphastar Pharmaceuticals Inc (:AMPH) has a price-to-earnings ratio of 10.48 and price/earnings-to-growth ratio is -0.25.